| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Prevymis 240 mg/12 mL injection, 12 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Prevymis 480 mg/24 mL injection, 24 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixvyda 100 mg/10 mL injection, 2 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixvyda 500 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixonfya 100 mg/10 mL injection, 3 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixvyda 500 mg/50 mL injection, 2 x 50 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixvyda 100 mg/10 mL injection, 3 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixonfya 500 mg/50 mL injection, 50 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixonfya 100 mg/10 mL injection, 2 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rixonfya 500 mg/50 mL injection, 2 x 50 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Jetrea RTU 375 microgram/0.3 mL intraocular injection, 0.3 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gliolan 1.5 g powder for oral liquid, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (Panpharma) 1 g powder for injection, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Gliolan 1.5 g powder for oral liquid, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gliolan 1.5 g powder for oral liquid, 2 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Kabi) 200 microgram/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Kabi) 200 microgram/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Quinine Dihydrochloride (Phebra) 600 mg/10 mL (6%) injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Xgeva 120 mg/1.7 mL injection, 4 x 1.7 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Ontruzant (trastuzumab 150 mg) powder for injection, 1 x 150 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Metaraminol (Phebra) 5 mg/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Metaraminol (Phebra) 3 mg/6 mL injection, 5 x 6 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (Panpharma) 1 g powder for injection, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Primovist 1.81 g/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Primovist 1.81 g/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Primovist 1.81 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Ogivri (trastuzumab 150 mg) powder for injection, 1 x 150 mg vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcidrox 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (DRLA) 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcidrox 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (DRLA) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (DRLA) 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemicor 200 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemicor (gemcitabine 1 g) powder for injection, 1 x 1 g vial (containered trade product pack) |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemicor 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcidrox 2 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Synflorix injection, 10 x 0.5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Mylan) 200 microgram/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Mylan) 200 microgram/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Mylan) 200 microgram/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Synflorix injection, 0.5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 1 g/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 1 g/10 mL injection, 4 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 1 g/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 400 mg/4 mL injection, 5 x 4 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 300 mg/3 mL injection, 3 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 400 mg/4 mL injection, 4 x 4 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 300 mg/3 mL injection, 5 x 3 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 300 mg/3 mL injection, 4 x 3 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Valproate (AFT) 400 mg/4 mL injection, 4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (AN) 200 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (GA) 1 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (GA) 200 mg/20 mL injection, 20 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Gemcitabine (AN) 1 g/100 mL injection, 100 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (SXP) 1 g powder for injection, 10 vials |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Erythromycin (SXP) 1 g powder for injection, 1 vial |
has container type |
False |
vial |
Inferred relationship |
Some |
|
| Takhzyro 300 mg/2 mL injection, 2 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Imfinzi 500 mg/10 mL injection, 10 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Imfinzi 120 mg/2.4 mL injection, 2.4 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Indigo Carmine (Micro-Tech) 0.4% (60 mg/15 mL) solution, 10 x 15 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Abraxane 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Abraxane 250 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Adsine 6 mg/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (MaxRx) 500 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Meropenem (MaxRx) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Adsine 6 mg/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Adsine 6 mg/2 mL injection, 10 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Ceftazidime (Juno) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Daptomycin (Panpharma) 350 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Ceftazidime (Juno) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Ceftazidime (Juno) 1 g powder for injection, 5 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Octreotide (DBL) 50 microgram/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Octreotide (DBL) 100 microgram/mL injection, 1 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Levetiracetam (Sun) 500 mg/5 mL injection, 10 x 5 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Primaxin powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Hydralazine (Link) 20 mg/mL injection, 10 x 1 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Rapivab 200 mg/20 mL injection, 3 x 20 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Adenosine (Claris) 30 mg/10 mL injection, 5 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Adenosine (Claris) 30 mg/10 mL injection, 10 x 10 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Daptomycin (Panpharma) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (Link) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Pemetrexed (Sun) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Pemetrexed (Sun) 100 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Pemetrexed (Sun) 500 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Esomeprazole (Sun) 40 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Esomeprazole (Sun) 40 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Vecuronium (Sun) 10 mg powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Teva) 200 microgram/2 mL injection, 5 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Vecuronium (Sun) 10 mg powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Dexmedetomidine (Teva) 200 microgram/2 mL injection, 25 x 2 mL vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Vecuronium (Sun) 10 mg powder for injection, 20 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Paclitaxel (Accord) 30 mg/5 mL injection, 5 mL vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Vecuronium (Sun) 10 mg powder for injection, 4 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (DBL) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (DBL) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (SXP) 1 g powder for injection, 10 vials |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythrocin IV 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|
| Erythromycin (SXP) 1 g powder for injection, 1 vial |
has container type |
True |
vial |
Inferred relationship |
Some |
|